Icariside II enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells

Although cisplatin is the most effective first-line drug in the management of advanced non-small cell lung cancer (NSCLC), drug resistance remains a major clinical challenge. There is increasing evidence that icariside II (IS) exhibits antitumour activity in a variety of cancers. In the current stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zhao, Du, Wenjing, Xu, Fei, Sun, Xianjun, Chen, Wenjing, Cui, Jie, Tang, Weifeng, Yang, Fangyong, Teng, Fangzhou, Lin, Jinpei, Liu, Baojun, Dong, Jingcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935239/
https://www.ncbi.nlm.nih.gov/pubmed/35342361
http://dx.doi.org/10.7150/ijbs.66630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935239/
https://www.ncbi.nlm.nih.gov/pubmed/35342361
http://dx.doi.org/10.7150/ijbs.66630

Ejemplares similares